- Approval Id
- 1c120eefba932dd1
- Drug Name
- DECA-DURABOLIN INJECTION 25 mg/ml
- Product Name
- DECA-DURABOLIN INJECTION 25 mg/ml
- Approval Number
- SIN04300P
- Approval Date
- 1990-04-20
- Registrant
- DCH AURIGA SINGAPORE
- Licence Holder
- DCH AURIGA SINGAPORE
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION
- Dosage
- **4.2 Posology and method of administration**
Deca-Durabolin should be administered by deep intramuscular injection.
For treatment of osteoporosis: 50 mg once every 3 weeks
For the palliative treatment of selected cases of disseminated mammary carcinoma in women: 50mg every 2 – 3 weeks
As an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance: 25–50 mg every 3 weeks.
N.B. For an optimal therapeutic effect it is necessary to administer adequate amounts of vitamins, minerals and protein in a calorie-rich diet.
Safety and efficacy have not been adequately determined in children and adolescents (see section 4.4 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
- Route Of Administration
- INTRAMUSCULAR
- Indication Info
- **4.1 Therapeutic indications**
- Treatment of osteoporosis
- For the palliative treatment of selected cases of disseminated mammary carcinoma in women.
- As an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance
- Contraindications
- **4.3 Contraindications**
- Pregnancy (see Section 4.6 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_)
- Known or suspected carcinoma of the prostate or breast in the male (see section 4.4 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_)
- Hypersensitivity to the active substance or to any of the excipients, including arachis oil. Deca-Durabolin is therefore contraindicated in patients allergic to peanuts or soya (see section 4.4 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_)
- Atc Code
- A14AB01
- Atc Item Name
- nandrolone
- Pharma Manufacturer Name
- DCH AURIGA SINGAPORE
- Company Detail Path
- /organization/dch-auriga-singapore
